POP-OUT | CLOSE
 
 
MYCOPHENOLIC ACID
 
MOA is found in 7 entries
MOA
  •   Chemical Component Summary   Hide
    Name MYCOPHENOLIC ACID
    Identifiers (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid
    (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methyl-hex-4-enoic acid
    Synonyms 6-(1,3-DIHYDRO-7-HYDROXY-5-METHOXY-4-METHYL-1-OXOISOBENZOFURAN-6
    -YL)-4-METHYL-4-HEXANOIC ACID
    Formula C17 H20 O6
    Molecular Weight 320.34 g/mol
    Type non-polymer
    Isomeric SMILES
    InChI
    InChI key HPNSFSBZBAHARI-RUDMXATFSA-N
     
  •   Drug Info: DrugBank Hide
    DrugBank ID DB01024   (Stereoisomeric match)
    Name Mycophenolic acid
    Groups approved
    Description Mycophenolic acid is an an immunosuppresant drug and potent anti-proliferative, and can be used in place of the older anti-proliferative azathioprine. It is usually used as part of triple therapy including a calcineurin inhibitor (ciclosporin or tacrolimus) and prednisolone. It is also useful in research for the selection of animal cells that express the E. coli gene coding for XGPRT (xanthine guanine phosphoribosyltransferase).
    Synonyms
    • (e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
    • Acide mycophenolique
    • Acido micofenolico
    • Acidum mycophenolicum
    • Micofenolico acido
    • Mycophenoic acid
    • Mycophenolate
    • Mycophenolsaeure
    [more]
    Brand names
    • Melbex
    • Myfortic
    Affected organism Humans and other mammals
    Indication For the prophylaxis of organ rejection in patients receiving allogeneic renal transplants, administered in combination with cyclosporine and corticosteroids.
    Pharmacology Mycophenolic acid is an antibiotic substance derived from <i>Penicillium stoloniferum</i>. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase. Mycophenolic acid is important because of its selective effects on the immune system. It prevents the proliferation of T-cells, lymphocytes, and the formation of antibodies from B-cells. It also may inhibit recruitment of leukocytes to inflammatory sites.
    Mechanism of action Mycophenolic acid is a potent, selective, uncompetitive, and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH), and therefore inhibits the de novo pathway of guanosine nucleotide synthesis without incorporation into DNA. Because T- and B-lymphocytes are critically dependent for their proliferation on de novo synthesis of purines, whereas other cell types can utilize salvage pathways, mycophenolic acid has potent cytostatic effects on lymphocytes. Mycophenolic acid inhibits proliferative responses of T- and B-lymphocytes to both mitogenic and allospecific stimulation. Addition of guanosine or deoxyguanosine reverses the cytostatic effects of mycophenolic acid on lymphocytes. Mycophenolic acid also suppresses antibody formation by B-lymphocytes. Mycophenolic acid prevents the glycosylation of lymphocyte and monocyte glycoproteins that are involved in intercellular adhesion to endothelial cells and may inhibit recruitment of leukocytes into sites of inflammation and graft rejection.
    Route of administration Oral
    Categories
    • Enzyme Inhibitors
    • Antibiotics, Antineoplastic
    AHFS-Code 92:00.00
    CAS number 24280-93-1
    Targets
    Name Sequence search Pharmacological action Actions
    Inosine-5'-monophosphate dehydrogenase 2   Search  yes inhibitor
    Inosine-5'-monophosphate dehydrogenase 2   Search  yes inhibitor
    Inosine-5'-monophosphate dehydrogenase 1   Search  yes inhibitor
    Inosine-5'-monophosphate dehydrogenase 1   Search  yes inhibitor
     
Ligand Image